CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 77 filers reported holding CTI BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62 | -54.1% | 14,801 | -34.2% | 0.00% | – |
| Q4 2022 | $135 | -99.9% | 22,489 | -44.3% | 0.00% | – |
| Q3 2022 | $234,000 | -59.0% | 40,371 | -57.9% | 0.00% | -100.0% |
| Q2 2022 | $571,000 | -22.8% | 95,799 | -39.6% | 0.00% | 0.0% |
| Q1 2022 | $740,000 | +264.5% | 158,481 | +93.0% | 0.00% | – |
| Q4 2021 | $203,000 | +968.4% | 82,126 | +1128.0% | 0.00% | – |
| Q1 2021 | $19,000 | – | 6,688 | +411.3% | 0.00% | – |
| Q4 2020 | $0 | – | 1,308 | +1276.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 95 | -98.6% | 0.00% | – |
| Q1 2019 | $6,000 | -94.3% | 6,997 | -85.7% | 0.00% | – |
| Q3 2018 | $105,000 | +1650.0% | 48,819 | +3808.6% | 0.00% | – |
| Q2 2018 | $6,000 | +200.0% | 1,249 | +67.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |